Patient Search
 |
 |
|
KaCrole Higgins was diagnosed with breast cancer in 2020. “In May 2020, I found a lump in my breast. I cried. By June, it was diagnosed as breast cancer, triple positive, stage 1A. While getting this cancer diagnosis was devastating, it also became an opportunity. Suddenly, the cancer gave me clarity. It gave me clarity about what was important, what was good in my life, what was toxic in my life, and what I needed to do.” Click below to read more of KaCrole’s story |
If Landon Ryan had been diagnosed with bilateral retinoblastoma 10, 20 or 30 years ago, she might not be here today with nearly perfect vision.Thanks to recent improvements in the treatment for this rare form of cancer that almost exclusively affects children under the age of 5, the diagnosis had the power to change Landon’s life when she was 11 months old, but not to take it — or her eyesight. Click below to learn more about Landon and her story. https://momentum.vicc.org/2022/04/brighter-outlook/ |
A Randomized Phase 2 Non-inferiority Trial of (Z)-endoxifen and Exemestane + Goserelin as Neoadjuvant Treatment for Premenopausal Women with ER+/HER2- Breast Cancer.
Breast
Breast
Breast
II
Abramson, Vandana
NCT05607004
VICCBRE22108
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Microsatellite Stable Colorectal Cancer
Multiple Cancer Types
Colon,
Gastrointestinal,
Rectal
II
Ciombor, Kristen
NCT06992258
VICCGI25032
A Randomized Clinical Trial Comparing ctDNA-directed Therapy Change with Standard of Care in Patients with Metastatic Triple Negative Breast Cancer
Breast
Breast
Breast
II
Abramson, Vandana
NCT05770531
VICCBRE2257
Phase II Open-Label Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures
Head/Neck
Head/Neck
Head/Neck
II
Rosenthal, Eben
NCT04511078
VICCHN21109
A Phase 2, Open-Label, Multicenter Study of BMS-986393, a GPRC5D-directed CAR T Cell Therapy in Adult Participants with Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)
Multiple Myeloma
Multiple Myeloma
Multiple Myeloma
II
Baljevic, Muhamed
NCT06297226
VICC-DTCTT23527
Prospective Observational Trial of Two Neoadjuvant Hypofractionated Radiotherapy Regimens Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas
Sarcoma
Sarcoma
Sarcoma
II
Shinohara, Eric
NCT04506008
VICCSAR2062
A Phase 2 Trial of Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome Undergoing Reduced Intensity or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation with Orca-T
Multiple Cancer Types
Leukemia,
Myelodysplastic Syndrome
II
Dholaria, Bhagirathbhai
NCT07216443
VICCCTT25025
A Randomized Phase 2 Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-Line Advanced Renal Cell Carcinoma (RCC)
Kidney (Renal Cell)
Kidney (Renal Cell)
Kidney (Renal Cell)
II
Rini, Brian
NCT07188896
VICCURO24517
Open-Label, Single-Arm Phase 2 Study of Nogapendekin Alfa Inbakicept, Pd-L1 T-Hank, and Bevacizumab and Randomized Phase 2b Study of Nogapendekin Alfa Inbakicept, Bevacizumab, and Tumor Treatment Fields with or without Pd-L1 T-Hank in Participants with Recurrent or Progressive Glioblastoma
Not Available
II
Merrell, Ryan
NCT06061809
VICC-DTNEU24006
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
Multiple Cancer Types
Breast,
Gastrointestinal,
Gynecologic,
Head/Neck,
Lung,
Melanoma,
Neuro-Oncology,
Sarcoma,
Urologic
II
Choe, Jennifer
NCT05564377
VICC-NTMDT23238
